World Orphan Drug Congress USA 2027

America's Largest Orphan Drug & Rare Disease Event, the World Orphan Drug Congress USA focuses on breaking barriers and fostering collaboration within the rare disease community. It brings together leading pharmaceutical and biotechnology companies, government and regulators, patient advocates, payers, investors, and solution providers. Attendees can expect to convene and brainstorm ways to advance Orphan Drug development and improve access to life-saving therapies for rare disease patients. The event offers access to a premium conference, exhibition, and networking opportunities with thousands of industry leaders, covering the latest developments in the rare disease and orphan drug space from top thought leaders, innovative products, and solutions revolutionizing the future of rare disease. Key topics include patient data, next-generation therapies, payer strategies, clinical development & regulatory affairs, commercial strategies, rare disease advocacy, global market & patient access, pricing & reimbursement, pitch & partner opportunities, advanced therapies manufacturing and clinical development, rare oncology, digital health & artificial intelligence, diagnosis, and discovery.